[1]
A. Azad, R. A. Herbertson, D. Pook, S. White, P. L. R. Mitchell, and N. C. Tebbutt, “Motesanib diphosphate (AMG 706), an oral angiogenesis inhibitor, demonstrates clinical efficacy in advanced thymoma”, AO, vol. 48, no. 4, pp. 619–621, Jan. 2009.